Abstract
The advent of hybridoma technology has provided an unlimited supply of monoclonal, ‘monospecific’ antibodies (Mab) that has fueled an unprecedented surge in the study of tumor immunology and biology [1]. For the first time, investigators have at their disposal a continuous source of pure antibody that makes possible the identification and extensive characterization of a wide variety of tumor antigens expressed by human carcinomas, melanomas, leukemias, and lymphomas. Subsequent studies have also led to the development of novel assays using Mabs for tumor diagnosis [2–5], as well as a variety of clinical protocols demonstrating radioimmunolocalization of an antibody to occult lesions in a variety of cancer patients [6–15]. In addition to these clinical studies, the use of immunohistochemical techniques, radioimmunoassays (RIA), Western blotting, and other experimental analyses have led to a better understanding of some of the basic principles that characterize tumor antigen expression.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kohler, M., and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of pre-defined specificity. Nature 256:295–297.
Bast, R.C., Jr., Klug, T.L., St. John, E., Jenison, E., Niloff, J.M., Lazarus, H., Berkowitz, R.S., Leavitt, T., Griffiths, T., Parker, L., Zurawski, V.R. Jr., and Knapp, R.C. (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309:883–887.
Metzgar, R.A., Rodriguez, N., Finn, O.J., Lan, M.S., Daasch, V.N., Fernsten, P.D., Meyers, W.C., Sindelar, W.F., Sandler, R.S., and Seigier, H.F. (1984) Detection of a pancreatic cancer associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc. Natl. Acad. Sci. USA 81:5242–5246.
Ritts, R.E., Del Villano, B.C., Go, W.L.M., Herberman, R.B., Klug, T.L., and Zurawski, V.R., Jr. (1984) Initial clinical evaluation of an immunoradiometric assay for CA 19–9 using the NCI serum bank. Int. J. Cancer 33:339–345.
Klug, T.L., Sattler, M.A., Colcher, D., and Schlom, J. (1986) Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72). Int. J. Cancer 38:661–669.
Mach, J.P., Buchegger, F., Forni, M., Ritschard, J., Berche, C., Lumbroso, J.D., Schreyer, M., Girardet, C., Accolla, R.S., and Carrel, S. (1981) Use of radiolabeled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol. Today 2:239–249.
Moldofsky, P.J., Powe, J., Mulhern, C.B., Jr., Hammond, N., Sears, H.F., Gatenby, R.A., Steplewski, Z., and Koprowski, H. (1983) Metastatic colon carcinoma detected with radiolabeled F(ab’)2 monoclonal antibody fragments. Radiology 149:549–555.
Mach, J.P., Chatal, J.F., Lumbroso, J.D., Buchegger, F., Forni, M., Ritschard, J., Berche, C., Douillard, J.Y., Carrel, S., Herlyn, M., Steplewski, Z., and Koprowski, H. (1983) Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma. Cancer Res. 43:5593–5600.
Hontowich, D.J., Griffin, T.W., Kosciuczyk, C., Rusckowski, M., Childs, R.L., Mattis, J.A., Shealy, D., and Doherty, P.W. (1985) Pharmacokinetics of an indium-111 labeled monoclonal antibody in cancer patient. J. Nucl. Med. 26:849–858.
Epenetos, A.A., Britton, K.E., Mather, S., Shepherd, J., Granowska, M., Taylor-Papadimitriou, J., Nimmon, C.C., Durbin, H., Hawkins, L.R., Malpas, J.S., and Bodmer, W.F. (1982) Targeting of iodine-123-labeled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumors. Lancet 2:999–1004.
Murray, J.L., Rosenblum, M.G., Sobol, R.E., Bartholomew, R.M., Plager, C.E., Haynie, T.P., Jahns, M.F., Glenn, H.J., Lamki, L., Benjamin, R.S., Papadopoulos, N., Boddie, A.W., Frincke, J.M., David, G.S., Carlo, D.J., and Hersh, E.M. (1985) Radioimmuno-imaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5. Cancer Res. 45:2376–2381.
Larson, S.M. (1985) Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy. J. Nucl. Med. 26:538–545.
Epenetos, A.A., Hooker, G., Krausz, T., Snook, D., Bodmer, W.F., and Taylor-Papadimitriou, J. (1986) Antibody-guided irradiation of malignant ascites in ovarian cancer: A new therapeutic method possessing specificity against cancer cells. Obstet. Gynecol. 68: 715–745.
Colcher, D., Esteban, J.E., Carrasquillo, J.A., Sugarbaker, P., Reynolds, J.C., Bryant, G., Larson, S.M., and Schlom, J. (1987) Quantitative analysis of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients. Cancer Res. 47:1185–1189.
Colcher, D., Esteban, J.E., Carrasquillo, J.A., Reynolds, J.C., Bryant, G., Larson, S.M., and Schlom, J. (1987) Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma. Cancer Res. 47:4218–4224.
Colcher, D., Hand, P., Nuti, M., and Schlom, J. (1981) A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc. Natl. Acad. Sci. USA 78:3199–3203.
Nuti, M., Teramoto, Y.A., Mariani-Costantini, R., Horan Hand, P., Colcher, D., and Schlom, J. (1982) A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell population. Int. J. Cancer 29: 539–545.
Johnson, V.G., Schlom, J., Paterson, A.J., Bennett, J., Magnani, J.L., and Colcher, D. (1986) Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res. 46:850–857.
Thor, A., Viglione, M.J., Muraro, R., Ohuchi, N., Schlom, J., and Gorstein, F. (1987) Monoclonal antibody B72.3 reactivity with human endometrium: A study of normal and malignant tissues. Int. J. Gynecol. Oncol. 6:235–247.
Thor, A., Ohuchi, N., Szpak, C.A., Johnston, W.W., and Schlom, J. (1986) The distribution of oncofetal antigen TAG-72 recognized by monoclonal antibody B72.3. Cancer Res. 46: 3118–3124.
Horan Hand, P., Nuti, M., Colcher, D., and Schlom, J. (1983) Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens, Cancer Res. 43:728–735.
Schlom, J., Colcher, D., Horan Hand, P., Wunderlich, D., Nuti, M., and Teramoto, Y.A. (1983) Antigenic heterogeneity, modulation and evolution in breast cancer lesions as defined by monoclonal antibodies. In: Rich, M., Hager, J., and Furmanski, P. (eds.), Understanding Breast Cancer: Clinical and Laboratory Concepts. New York: Marcel Dekker, pp. 169–213.
Barnstable, C.J., Bodmer, W.F., Brown, G., Galfre, G., Milstein, C., Williams, A.F., and Ziegler, A. (1978) Production of monoclonal antibodies to group A erythrocytes, HLA and to the human cell surface antigens — new tools for genetic analysis. Cell 14:9–20.
Tran, R., Horan Hand, P., Greiner, J.W., Pestka, S., and Schlom, J. (1988) Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons. J. Interferon Res. 8:75–88.
Muraro, R., Wunderlich, P., Thor, A., Lundy, J., Noguchi, P., Cunningham, R., and Schlom, J. (1985) Definition of monoclonal antibodies of a repertoire of epitopes in carcino-embryonic antigen differentially expressed in human colon carcinoma versus normal adult tissues. Cancer Res. 45:5769–5780.
Foulds, L. (1954) The experimental study of tumor progression: A review. Cancer Res. 14: 327–329.
Kufe, D.W., Nadler, L., Sargent, L., Shapiro, H., Horan Hand, P., Austin, F., Colcher, D., and Schlom, J. (1983) Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation. Cancer Res. 43:851–857.
Greiner, J.W., Tobi, M., Fisher, P.B., Langer, J.A., and Pestka, S. (1985) Differential responsiveness of cloned mammary carcinoma cell populations to human recombinant leukocyte alpha interferon mediated enhancement of human antigen expression. Int. J. Cancer 36:159–166.
Horan Hand, P., Colcher, D., Salomon, D., Ridge, J., Noguchi, P., and Schlom, J. (1985) Spacial configuration of carcinoma cell populations influences the expression of a tumor associated glycoprotein. Cancer Res. 45:833–840.
Fellous, M., Kamoun, M., Gresser, I., and Bono, R. (1979) Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells. Eur. J. Immunol. 9:446–449.
Attallah, A.M., Needy, C.F., Noguchi, P.D., and Elisberg, B.L. (1979) Enhancement of carcinoembryonic antigen expression by interferon. Int. J. Cancer 24:49–52.
Imai, K., Ng, A.-K., Glassy, M., and Ferrone, S.K. (1981) Differential effect of interferon on the expression of tumor-associated antigens and histocompatibility antigens on human melanoma cells: Relationship to susceptibility to immune lysis mediated by monoclonal antibodies. J. Immunol. 127:505–508.
Basham, T.Y., Bourgeade, M.F., Creasey, A.A., and Merigan, T.C. (1982) Interferon increases HLA synthesis in melanoma cells: Interferon-resistant and sensitive cell lines. Proc. Natl. Acad. Sci. USA 79:3265–3269.
Ball, E.D., Sorenson, G.D., and Pettengill, O.S. (1986) Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cells analyzed by cytofluorometry: Modulation by interferon. Cancer Res. 46:2335–2339.
Greiner, J.W., Horan Hand, P., Noguchi, P., Fisher, P., Pestka, S., and Schlom, J. (1984) Recombinant interferon enhances detection of human breast and colon carcinoma associated antigens by monoclonal antibodies. Cancer Res. 44:3208.
Dolei, A., Capobianchi, M.R., and Ameglio, F. (1983) Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta. Infect. Immunol. 40:172–176.
Schwartz, R., Momberg, F., Moldenbauer, G., Dorken, B., and Schirrmacher, V. (1985) Induction of class II antigen expression on human carcinoma cell lines by IFN-gamma. Int. J. Cancer 35:245–250.
Ziai, M.R., Imbesti, L., Tongson, A., and Ferrone, S. (1985) Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon. Cancer Res. 45:5877–5882.
Greiner, J.W. (1986) Modulation of antigen expression in human tumor cell populations. Cancer Invest. 4:239.
Giacomini, P., Aguzzi, A., and Ferrone, S. (1986) Differential susceptibility to modulation by recombinant immune interferon of HLA-DR and -DO antigens synthesized by melanoma COLO 38 cells. Hybridoma 5:277–288.
Heron, I., Hokland, M., and Berg, K. (1978) Enhanced expression of β2-microglobulin and HLA antigen on human lymphoid cells by interferon. Proc. Natl. Acadi. Sci. USA 75: 6215–6219.
Wallach, D., Fellous, M., and Revel, M. (1982) Preferential effect of gamma-interferon on the synthesis of HLA antigens and their mRNAs. Nature 299:833–836.
Collins, T., Karman, A.J., Wake, C.T., Boss, J.M., Kappes, D.J., Fiers, W., Ault, K.A., Gimbrone, M.A., Strominger, J.L., and Pober, J.S. (1984) Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917–4921.
Greiner, J.W., Guadagni, F., Pestka, S., and Schlom, J. (1986) Augmentation of antigen expression by recombinant human interferon. In: Friedman, R., Merigan, T., and Sreevalsan, T. (eds.), UCLA Symposium on Molecular and Cellular Biology, Vol 50. New York: Alan R. Liss, pp. 17–27.
Chandrabase, K., and Cuatrecasas, P. (1981) Changes in fatty acyl chains of phospholipid induced by interferon in mouse sarcoma S-180. Biochem. Biophys. Res. Commun. 98: 661–665.
Kuhry, J.G., Poindoin, and Laustriat, G. (1983) Evidence for early fluidity changes in the plasma membranes of interferon treated L-cells, from fluorescence antistropy data. Biochem. Biophys. Res. Commun. 110:88–92.
Spear, G.T., Paulnock, D.M., Jordan, R., Hawkins, M.J., and Borden, E.C. (1985) Modulation of human peripheral blood monocyte HLA-DR expression by recombinant IFN-γ. Proc. Am. Assoc. Cancer Res. 26:277.
Rowlinson, G., Balkwill, F., Snook, D., Hooker, G., and Epenetos, A.A. (1986) Enhancement by γ-interferon of in vivo tumor radiolocalization by a monoclonal antibody against HLA-DR antigen. Cancer Res. 46:6413–6417.
Balkwill, F.R., Stevens, M.H., Griffin, D.B., Thomas, J.A., and Bodmer, J.G. (1987) Interferon gamma regulates HLA-DR expression on solid tumors in vivo. Eur. J. Clin. Oncol. 23:101–106.
Hayes, D.F., Zalutsky, M.R., Kaplan, W., Noska, M, Thor, A., Colcher, D., and Kufe, D.W. (1986) Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer. Cancer Res. 46:3157–3163.
Colcher, D., Zalutsky, M., Kaplan, W., Kufe, D., Austin, F., and Schlom, J. (1983) Radio-localization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res. 43:736–742.
Sahagan, B.G., Dorai, H., Saltygaber-Muller, J., Toneguzzo, F., Guidon, C.A., Lilly, S.P., McDonald, K.W., Morrissey, D.V., Stone, B.A., Davis, G.L., McIntosh, P.K., and Moore, G.P. (1986) A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen. J. Immunol. 137:1066–1074.
Thor, A., Muraro, R., Gorstein, F., Ohuchi, N., Viglione, M., Szpak, C.A., Johnston, W.W., and Schlom, J. (1987) Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcino-embryonic antigen activity. Cancer Res. 47:505–512.
Schlom, J., Greiner, J.W., Horan-Hand, P., Colcher, D., Inghirami, G., Weeks, M., Pestka, S., Fisher, P.B., Noguchi, P., and Kufe, D.W. (1985) Human breast cancer markers defined by monoclonal antibodies. In: Sell, S., and Reisfeld, R. (eds.), Monoclonal Antibodies in Cancer. Clifton, NJ: Humana Press, pp. 247–277.
Greiner, J.W., Horan Hand, P., Wunderlich, D., and Colcher, D. (1986) Radioimmunoassay for detection of changes in cell surface tumor antigen expression induced by interferon. Meth. Enzymol. 119:682–685.
Braylan, R.C., Benson, N.A., Nourse, V., and Kruth, H.S. (1982) Correlated analysis of cellular DNA, membrane antigens and light scatter of human lymphoid cells. Cytometry 2: 337–343.
Basham, T.Y., Kaminski, M.S., Kitamura, K., Levy, R., and Merigan, T.C. (1986) Synergistic antitumor effect of interferon and anti-idiotype monoclonal antibody in murine lymphoma. J. Immunol. 137:3019–3024.
Herlyn, D., Powe, J., Ross, A.H., Herlyn, M., and Koprowski, H. (1985) Inhibition of human tumor growth by IgG2a monoclonal antibodies correlates with antibody density on tumor cells. J. Immunol. 134:1300–1304.
Herlyn, D., and Koprowski, H. (1982) IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc. Natl. Acad. Sci. USA 79:4761–4768.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Greiner, J.W. et al. (1990). Augmentation of tumor antigen expression by recombinant human interferons: Enhanced targeting of monoclonal antibodies to carcinomas. In: Goldenberg, D.M. (eds) Cancer Imaging with Radiolabeled Antibodies. Cancer Treatment and Research, vol 51. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1497-4_21
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1497-4_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8805-3
Online ISBN: 978-1-4613-1497-4
eBook Packages: Springer Book Archive